Evaluation of levodopa dose and magnitude of dopamine depletion as risk factors for levodopa-induced dyskinesia in a rat model of Parkinson's disease.
Journal of Pharmacology and Experimental Therapeutics
Chronic dopamine depletion augments the functional expression of K-ATP channels in the rat subthalamic nucleus.
Neurosci. Lett., Dec;531(2):104-8 (2012)
Clinical impact of switching conventional enzyme immunoassay with nucleic acid amplification test for suspected Clostridium difficile-associated diarrhea.
Am J Infect Control., Oct (2012)
Anti-dyskinetic mechanisms of amantadine and dextromethorphan in the 6-OHDA rat model of Parkinson's disease: role of NMDA vs. 5-HT1A receptors.
Eur. J. Neurosci., Nov;36(9):3224-34 (2012)
NMDA alters rotenone toxicity in rat substantia nigra zona compacta and ventral tegmental area dopamine neurons.
Neurotoxicology., Jun;33(3):429-35 (2012)
Regulation of polysynaptic subthalamonigral transmission by D2, D3 and D4 dopamine receptors in rat brain slices.
J. Physiol. (Lond.)., May;590(Pt 10):2273-84 (2012)
Evaluation of the aesthetics of physical methods of euthanasia of anesthetized rats.
J. Am. Assoc. Lab. Anim. Sci., Sep;50(5):695-701 (2011)
Gamma-aminobutyric acid(B) receptor activation suppresses stimulus-evoked burst firing in rat substantia nigra reticulata neurons.
Neuroreport., Jan;23(1):40-4 (2012)
Dopamine oxidation facilitates rotenone-dependent potentiation of N-methyl-D-aspartate currents in rat substantia nigra dopamine neurons.
Neuroscience., Nov;195:138-44 (2011)
Mitochondrial uncoupling agents antagonize rotenone actions in rat substantia nigra dopamine neurons.
Brain Res., Jun;1395:86-93 (2011)
Platinum(II) complexes with bioactive carrier ligands having high affinity for the translocator protein.
J. Med. Chem., Jul;53(14):5144-54 (2010)
Pharmacogenomic identification of c-Myc/Max-regulated genes associated with cytotoxicity of artesunate towards human colon, ovarian and lung cancer cell lines.
Molecules., Apr;15(4):2886-910 (2010)
Ca2+ influx through NMDA-gated channels activates ATP-sensitive K+ currents through a nitric oxide-cGMP pathway in subthalamic neurons.
J. Neurosci., Feb;30(5):1882-93 (2010)
MK-801 inhibits L-DOPA-induced abnormal involuntary movements only at doses that worsen parkinsonism.
Neuropharmacology., Jun;58(7):1002-8 (2010)
Design, synthesis, and investigation of protein kinase C inhibitors: total syntheses of (+)-calphostin D, (+)-phleichrome, cercosporin, and new photoactive perylenequinones.
J. Am. Chem. Soc., Jul;131(26):9413-25 (2009)
Rotenone reduces Mg2+-dependent block of NMDA currents in substantia nigra dopamine neurons.
Neurotoxicology., Mar;30(2):320-5 (2009)
The sigma-1 antagonist BMY-14802 inhibits L-DOPA-induced abnormal involuntary movements by a WAY-100635-sensitive mechanism.
Psychopharmacology (Berl.)., Jul;204(4):743-54 (2009)
Rebound bursts following inhibition: how dopamine modifies firing pattern in subthalamic neurons.
J. Physiol. (Lond.)., Apr;586(8):2033 (2008)
Sigma ligands, but not N-methyl-D-aspartate antagonists, reduce levodopa-induced dyskinesias.
Neuroreport., Jan;19(1):111-5 (2008)
5-HT inhibits synaptic transmission in rat subthalamic nucleus neurons in vitro.
Neuroscience., Feb;151(4):1029-33 (2008)